TY - JOUR
T1 - The spirografic oxygen deficit
T2 - its role in cardiopulmonary exercise testing
AU - Sperlich, Billy
AU - Schiffer, Thorsten
AU - Hoffmann, Uwe
AU - Strüder, Heiko Klaus
AU - Hollmann, W
N1 - © Georg Thieme Verlag KG Stuttgart · New York.
PY - 2013/12/1
Y1 - 2013/12/1
N2 - The increase in oxygen uptake > 100 ml · min-1 during steady state exercise when elevating the inspired fractional air content (FinO2) from 0.21-1.00 defines the "spirografic oxygen deficit" (SOD). The purpose of this study was 2-fold: 1) determine the SOD at different exercise intensities in healthy participants and 2) investigate if a correlation exists among key variables of cardiopulmonary exercise testing. 12 men (24±2 yrs; 183±4 cm; 83.5±5.3 kg) performed cycle tests to determine maximal power output (Pmax), the power output at the first (PVT1) and the second ventilatory threshold (PVT2), at 4 mmol · l-1 blood lactate (P4) and lactate threshold (PLT). When cycling at 30, 40, 50, 60, 70 and 80% Pmax, the FinO2 was increased from 0.21-1.00 after 5 min to assess the power output at the SOD and at which blood lactate increased > 1 mmol∙L-1 (PLLAC). The SOD occurred at 70% Pmax accompanied by increased blood lactate concentration (p<0.01). The PSOD correlated with PLACC (p=0.05; r=0.61), but not with PVT1, PVT2, P4, or PLT (best p=0.29; highest r=0.39). In conclusion, the SOD may represent a non-invasive tool for evaluating submaximal endurance performance, especially when evaluating the peripheral contribution to performance.
AB - The increase in oxygen uptake > 100 ml · min-1 during steady state exercise when elevating the inspired fractional air content (FinO2) from 0.21-1.00 defines the "spirografic oxygen deficit" (SOD). The purpose of this study was 2-fold: 1) determine the SOD at different exercise intensities in healthy participants and 2) investigate if a correlation exists among key variables of cardiopulmonary exercise testing. 12 men (24±2 yrs; 183±4 cm; 83.5±5.3 kg) performed cycle tests to determine maximal power output (Pmax), the power output at the first (PVT1) and the second ventilatory threshold (PVT2), at 4 mmol · l-1 blood lactate (P4) and lactate threshold (PLT). When cycling at 30, 40, 50, 60, 70 and 80% Pmax, the FinO2 was increased from 0.21-1.00 after 5 min to assess the power output at the SOD and at which blood lactate increased > 1 mmol∙L-1 (PLLAC). The SOD occurred at 70% Pmax accompanied by increased blood lactate concentration (p<0.01). The PSOD correlated with PLACC (p=0.05; r=0.61), but not with PVT1, PVT2, P4, or PLT (best p=0.29; highest r=0.39). In conclusion, the SOD may represent a non-invasive tool for evaluating submaximal endurance performance, especially when evaluating the peripheral contribution to performance.
U2 - 10.1055/s-0033-1334877
DO - 10.1055/s-0033-1334877
M3 - Journal articles
C2 - 23670361
SN - 0172-4622
VL - 34
SP - 1074
EP - 1078
JO - International journal of sports medicine
JF - International journal of sports medicine
IS - 12
ER -